New York State Common Retirement Fund
MRVI icon

New York State Common Retirement Fund’s Maravai LifeSciences MRVI Stock Holding History

New York State Common Retirement Fund’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Hold
32,734
– – ﹤0.01% 2363
2026
Q1 		$92.6K Hold
32,734
– – ﹤0.01% 2568
2025
Q4 		$106K Hold
32,734
– – ﹤0.01% 2569
2025
Q3 		$93.9K Hold
32,734
– – ﹤0.01% 2649
2025
Q2 		$78.9K Hold
32,734
– – ﹤0.01% 2808
2025
Q1 		$72.3K Hold
32,734
– – ﹤0.01% 2655
2024
Q4 		$178K Hold
32,734
– – ﹤0.01% 2351
2024
Q3 		$272K Sell
32,734
-136,537
-81% -$1.18M ﹤0.01% 2171
2024
Q2 		$1.21M Buy
169,271
+10,771
+7% +$93K ﹤0.01% 1673
2024
Q1 		$1.37M Sell
158,500
-55,288
-26% -$374K ﹤0.01% 1628
2023
Q4 		$1.4M Buy
213,788
+4,079
+2% +$26.4K ﹤0.01% 1619
2023
Q3 		$2.1M Buy
209,709
+107,224
+105% +$1.18M ﹤0.01% 1435
2023
Q2 		$1.27M Sell
102,485
-23,578
-19% -$318K ﹤0.01% 1670
2023
Q1 		$1.77M Sell
126,063
-35,696
-22% -$513K ﹤0.01% 1601
2022
Q4 		$2.31M Buy
161,759
+24,255
+18% +$382K ﹤0.01% 1564
2022
Q3 		$3.51M Buy
137,504
+21,617
+19% +$542K 0.01% 1328
2022
Q2 		$3.29M Sell
115,887
-2,833
-2% -$89.7K ﹤0.01% 1395
2022
Q1 		$4.19M Sell
118,720
-4,896
-4% -$164K ﹤0.01% 1364
2021
Q4 		$5.18M Buy
123,616
+7,483
+6% +$303K 0.01% 1285
2021
Q3 		$5.7M Buy
116,133
+32,333
+39% +$1.58M 0.01% 1259
2021
Q2 		$3.5M Buy
83,800
+39,000
+87% +$1.51M ﹤0.01% 1516
2021
Q1 		$1.6M Buy
+44,800
New +$1.48M ﹤0.01% 1908

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

New York State Common Retirement Fund's MRVI Position: Q2 2026 in Review

New York State Common Retirement Fund held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 32,734 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

New York State Common Retirement Fund first reported a position in MRVI in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.7M in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • New York State Common Retirement Fund held 32,734 shares of Maravai LifeSciences worth $204K as of Q2 2026.
  • New York State Common Retirement Fund left its Maravai LifeSciences share count unchanged in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2363 holding.
  • New York State Common Retirement Fund first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 22 quarters since.
  • New York State Common Retirement Fund's Maravai LifeSciences position peaked at $5.7M in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.